Clinical Trial Detail

NCT ID NCT02514668
Title A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Sanofi
Indications

multiple myeloma

Therapies

Isatuximab

Age Groups: senior adult

No variant requirements are available.